Many of the cancer-related mutations are associated with breast and/or ovarian cancer, and map to BRCA1, BRCA2 and their associated proteins involved in processes related to DNA synthesis and repair (e.g. CHEK2, BARD1, BRIP1 and TP53). This evidence concerns the gene TP53 and cancer.